Efficacy of Amitraz in the Treatment of Demodicosis in Small Breed Dogs
World Small Animal Veterinary Association World Congress Proceedings, 2005
S.R. Nourollahi-Fard; D.Vosough
Department of pathobiology, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman
Kerman, Iran

Introduction: Demodicosis is an inflammatory parasitic disease of dogs and rarely cats characterized by the presence of a high number of mites in the hair follicles and sebaceous glands. The efficacy of Amitraz was evaluated in three small breed dogs with localized demodicosis.

Materials and methods: Samples from head, thoracic and abdominal area, extremities and ear were taken by skin scraping and examined microscopically in 10% KOH solution to detect the presence of mites Amitraz topically applied as a 0.025% aqueous suspension once a week for up to four weeks together with antimicrobial therapy and a prewash of the entire skin surface with soap. At this dose the drug is non toxic and non irritant to skin and mucous membranes. The dips were done on a weekly basis until two negative skin scrapings. The treatment led to an entire healing and a complete resolution of the skin lesions and the disappearance of Demodex canis after two months without any scar formation or depigmentations of the skin.

Conclusions: The Amitraz therapy appears to provide a favorable prognosis for the control of demodicosis in the dogs with short hairs specially in breeds which have potential for Ivermectin poisoning.

Acknowledgements: We wish to thanks Dr. Hosseini for referring the cases for treatment.


1.  Agin H, et al. (2004) Amitraz poisoning: clinical and laboratory findings. Indian Pediatr. May. 41(5):482-6.

2.  Hugnet C. et al.(2001) Efficacy of 1.25% amitraz solution in the treatment of generalized demodicosis (eight cases) and sarcoptic mange (five cases) in dogs. Vet Dermatol. Apr. 12(2):89-92.

3.  Shaw SE et al. (2000) Treatment of canine adult-onset demodicosis. Aust Vet J. Apr. 78(4):243-4.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

S.R. Nourollahi-Fard

MAIN : Abstracts, Poster : Efficacy of Amitraz
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.


777 W. Covell Blvd., Davis, CA 95616



  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357